help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waeber, G.
Right arrow Articles by Grouzmann, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waeber, G.
Right arrow Articles by Grouzmann, E.

Endocrinology, Vol 133, 1061-1067, Copyright © 1993 by Endocrine Society


ARTICLES

Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line

G Waeber, N Thompson, B Waeber, HR Brunner, P Nicod and E Grouzmann
Department of Internal Medicine B, CHUV-1011 Lausanne, Switzerland.

Neuropeptide-Y (NPY) is a 36-amino acid peptide known to inhibit glucose-stimulated insulin secretion in various animal models in vitro and in vivo. NPY is thought to be one of the mediators of sympathetic action in the pancreas through nerve endings surrounding the islets, and it has recently been shown to be synthesized within the islets of Langerhans. To elucidate the potential role of NPY in the endocrine pancreas, we studied the expression and regulation of NPY secretion in a rat insulinoma cell line (INS-1). NPY mRNA and peptide are highly expressed and secreted by INS-1 cells. NPY levels were determined by a sensitive and specific two-site amplified enzyme-linked immunosorbent assay. Incubation of INS-1 cells with various glucose concentrations did not modify NPY secretion; however, stimulation of adenylate cyclase by forskolin induced a dose- and time-dependent increase in NPY release in the medium. The glucagon-like peptide-I-(7-36) amide (GLP-1), a known gluco-incretin in humans, induced at low concentration (10(-9) M) a similar expression of NPY mRNA and peptide secretion in INS-1 cells. On the other hand, the inhibition of cAMP accumulation by the alpha 2- adrenergic agonist clonidine decreased NPY secretion. In conclusion, 1) high levels of gene expression and secretion of NPY are found in a rat insulinoma cell line (INS-1). 2) Accumulation of cAMP induced by forskolin or a gluco-incretin (GLP-1) induces a further increase in NPY gene expression and release. 3) NPY secretion is not modulated by low or high glucose concentrations in the medium. 4) Induction of NPY, a known inhibitor of insulin secretion, may represent a novel counterregulatory mechanism of insulin secretion, limiting the stimulatory effect of GLP-1 on insulin secretion.


This article has been cited by other articles:


Home page
EndocrinologyHome page
Y. Imai, H. R. Patel, E. J. Hawkins, N. M. Doliba, F. M. Matschinsky, and R. S. Ahima
Insulin Secretion Is Increased in Pancreatic Islets of Neuropeptide Y-Deficient Mice
Endocrinology, December 1, 2007; 148(12): 5716 - 5723.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Arumugam, D. Fleenor, and M. Freemark
Lactogenic and Somatogenic Hormones Regulate the Expression of Neuropeptide Y and Cocaine- and Amphetamine-Regulated Transcript in Rat Insulinoma (INS-1) Cells: Interactions with Glucose and Glucocorticoids
Endocrinology, January 1, 2007; 148(1): 258 - 267.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. B. Gibson, M. C. Lawrence, C. J. Gibson, C. A. Vanderbilt, K. McGlynn, D. Arnette, W. Chen, J. Collins, B. Naziruddin, M. F. Levy, et al.
Inhibition of Glucose-Stimulated Activation of Extracellular Signal-Regulated Protein Kinases 1 and 2 by Epinephrine in Pancreatic {beta}-Cells.
Diabetes, April 1, 2006; 55(4): 1066 - 1073.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Possenti, A. M. Rinaldi, G.-L. Ferri, P. Borboni, E. Trani, and A. Levi
Expression, Processing, and Secretion of the Neuroendocrine VGF Peptides by INS-1 Cells
Endocrinology, August 1, 1999; 140(8): 3727 - 3735.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Waeber, T. Calandra, R. Roduit, J.-A. Haefliger, C. Bonny, N. Thompson, B. Thorens, E. Temler, A. Meinhardt, M. Bacher, et al.
Insulin secretion is regulated by the glucose-dependent production of islet beta  cell macrophage migration inhibitory factor
PNAS, April 29, 1997; 94(9): 4782 - 4787.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Myrsen-Axcrona, S. Karlsson, F. Sundler, and B. Ahren
Dexamethasone Induces Neuropeptide Y (NPY) Expression and Impairs Insulin Release in the Insulin-producing Cell Line RINm5F. RELEASE OF NPY AND INSULIN THROUGH DIFFERENT PATHWAYS
J. Biol. Chem., April 18, 1997; 272(16): 10790 - 10796.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B Thorens and J Roth
Intracellular targeting of GLUT4 in transfected insulinoma cells: evidence for association with constitutively recycling vesicles distinct from synaptophysin and insulin vesicles
J. Cell Sci., January 6, 1996; 109(6): 1311 - 1323.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society